MedTrace Logo

Validating Imaging Biomarkers of Small Vessel Disease in Diabetic Individuals Using Advanced MRI Techniques.

NCT03754608 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 63

Last updated 2021-04-19

No results posted yet for this study

Summary

To develop a set of biomarkers for imaging of small vessel disease in diabetic individuals using advanced MRI techniques. With this the investigators want to document progression of disease both radiologically and clinically.

Conditions

  • Small Vessel Disease of Diabetes Mellitus

Interventions

DIAGNOSTIC_TEST

MRI including cf-MRI, DTI, ASL and CVR.

A paradigm developed at Yale University called Cognitive Predictive Modelling which takes connectivity data and reduces it to two smaller network which predict higher and lower performance in a particular task for which these networks have been optimized. This will be supplemented by MRI vascular measures.

Sponsors & Collaborators

  • Yale University

    lead OTHER

Principal Investigators

  • Arash Salardini, MD · Yale University

Eligibility

Min Age
55 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-07
Primary Completion
2020-08-31
Completion
2020-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03754608 on ClinicalTrials.gov